11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Diffuse cystic lung disease in a child

      other

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A 3-year-old boy presented with fever and cough for 1 month and fast breathing for 20 days. He had no history of decreased appetite, weight loss or tuberculosis contact. There was no history of similar complaints in the past. Examination revealed a thin-built, tachypneic boy with no cyanosis or clubbing and bilateral, scattered, fine crepitations on auscultation. His arterial oxygen saturation was 92% on room air. Chest radiograph [Figure 1] showed bilateral reticular infiltrates with a few doubtful cystic lesions (arrow). Other investigations including complete blood count and tuberculosis work up were non-contributory. High-resolution computed tomography (HRCT) of the chest [Figure 2a and b] revealed bilateral diffuse cystic changes. Figure 1 Chest X ray showing bilateral reticular infiltrates with few doubtful cystic lesions Figure 2 (a) HRCT chest showing bilateral numerous cysts of variable size, shape and wall thickness with normal intervening lung parenchyma. (b) HRCT showing bilateral diffuse involvement of lung parenchyma and normal bronchial tree QUESTION What is the diagnosis? ANSWER Pulmonary Langerhans cell histiocytosis. Diagnosis was confirmed by lung biopsy showing characteristic features of LCH with immunopositivity for CD1a. There was no evidence of histiocytic involvement of any other organ system. Histiocytic involvement of lungs, as a part of multisystem disease, occurs in 23-50% of children with Langerhans cell histiocytosis (LCH), with isolated pulmonary LCH being rare in this population.[1] The presence of typical features on high-resolution computed tomography (HRCT) of chest allows the clinician to make a presumptive diagnosis of LCH. Most common HRCT findings of pulmonary LCH are bilateral cystic lesions of variable size (usually less than 20 mm), shape (round/ovoid/bilobed/cloverleaf) and wall thickness. The presence of nodules along with cystic lesions is nearly pathognomonic but is found early in disease course as lesions evolve sequentially from nodules, cavitated nodules and thick-walled cysts to thin-walled cyst and eventually confluent cysts.[2 3] Though, typically upper and middle lung zones are predominantly affected with sparing of lung bases, diffuse involvement has been described in pediatric population (as in the present case).[4 5 6] Main differential diagnoses of cystic lung disease on HRCT, apart from pulmonary LCH, include lymphangioleiomyomatosis with/without tuberous sclerosis, emphysema and bronchiectasis, which can be differentiated based on combination of clinical and imaging findings. Lymphangioleiomyomatosis and lung disease due to tuberous sclerosis occur in females of child bearing age and on HRCT cysts are small, thin walled, more regular in shape and uniformly distributed. Emphysematous cysts have no visible cyst wall and cysts follow bronchial pattern in cystic bronchiectasis. The child has been put on treatment as per German-Austrian-Dutch group HX-83 chemotherapy protocol.[7] Follow-up is planned with serial HRCT chest to assess the response to treatment.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Extra-osseous involvement of Langerhans' cell histiocytosis in children.

          The predominant clinical and radiological features of Langerhans' cell histiocytosis (LCH) in children are due to osseous involvement. Extra-osseous disease is far less common, occurring in association with bone disease or in isolation; nearly all anatomical sites may be affected and in very various combinations. The following article is based on a multicentre review of 31 children with extra-osseous LCH. The objective is to summarise the diverse possibilities of organ involvement. The radiological manifestations using different imaging modalities are rarely pathognomonic on their own. Nevertheless, familiarity with the imaging findings, especially in children with systemic disease, may be essential for early diagnosis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pulmonary Langerhans' cell histiocytosis.

            Pulmonary Langerhans' cell histiocytosis (PLCH) is an uncommon but important cause of interstitial lung disease, and it occurs predominantly in adult cigarette smokers. PLCH belongs to the spectrum of Langerhans' cell histiocytosis (LCH), diseases characterized by uncontrolled proliferation and infiltration of various organs by Langerhans' cells. Other clinical entities within this spectrum of LCH are seen in adults and children and vary in severity from mild disease that requires no therapy to severe disseminated forms with extensive organ involvement and high mortality. Organ systems involved by LCH may include skin, bone, pituitary gland, lymph nodes, and lungs. Although LCH is approximately three times more common in children than adults, pulmonary involvement is much more common in adults with LCH, in whom it frequently occurs as the sole organ involved with disease. This article summarizes recent advances and current understanding of PLCH.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.

              Treatment of Langerhans cell histiocytosis (LCH) remains problematic. To test the hypothesis that rapid initiation and long-term continuation of chemotherapy can improve survival and reduce recurrence and late consequences of disseminated LCH, we have completed a prospective clinical trial (DAL HX-83). One hundred six newly diagnosed patients were stratified into three risk groups (A: multifocal bone disease [n = 28]; B: soft tissue involvement without organ dysfunction [n = 57]; C: organ dysfunction [n = 21]). All patients received an identical initial 6-week treatment (etoposide [VP-16], prednisone, and vinblastine), and continuation treatment for 1 year, slightly adapted according to stratification at diagnosis. It included oral 6-mercaptopurine and eight pulses of vinblastine and prednisone for all patients, plus VP-16 in group B and VP-16 and methotrexate in group C. Eighty-nine percent and 91% of patients in groups A and B and 67% of the most severely affected group C, achieved complete resolution of disease. The speed of resolution was rapid (median 4 months) and independent of disease severity. The frequency of recurrence after initial resolution was low (12%, 23%, and 42% in groups A, B and C); overall fully 77% of patients have remained free of recurrence. Permanent consequences developed after diagnosis in 20% of the patients. Diabetes insipidus after initiation of treatment occurred in only 10% of patients. Mortality (9%) was limited to patients of groups B (two patients) and C (eight patients). Finally, among the 106 patients treated by DAL HX-83 none have developed a malignancy (median follow-up 6 years, 9 months). The shorter duration of active disease, low rate of recurrence and permanent consequences, and improved survival among patients with poor prognosis support the strategy of rapid initiation of a predefined prolonged treatment upon the diagnosis of disseminated LCH.
                Bookmark

                Author and article information

                Journal
                Lung India
                Lung India
                LI
                Lung India : Official Organ of Indian Chest Society
                Medknow Publications & Media Pvt Ltd (India )
                0970-2113
                0974-598X
                Mar-Apr 2015
                : 32
                : 2
                : 186-187
                Affiliations
                [1] Department of Pediatrics, Maulana Azad Medical College, Delhi, India
                Author notes
                Address for correspondence: Dr. Satnam Kaur, Department of Pediatrics, Maulana Azad Medical College, 2 BSZ Marg, Delhi - 110 002, India. E-mail: sk_doc@ 123456yahoo.co.in
                Article
                LI-32-186
                10.4103/0970-2113.152653
                4372880
                c799976d-3031-4d68-bbad-37e18e620768
                Copyright: © Lung India

                This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                Categories
                Radiology Quiz

                Respiratory medicine
                Respiratory medicine

                Comments

                Comment on this article